Ratings Moves: AIR,...
Technology: Electronics
Cepheid (CPHD: NASDAQ)
$38.27 -0.25 | -0.65%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 38.27 |
| 52 Week High | 46.00 |
| 52 Week Low | 28.12 |
| Avg. Daily Vol. (Mil) | 0.41 |
| Beta (3 year) | 1.09 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,568.16 |
| Shares Out (Mil) | 67.11 |
| Float (Mil) | 51.25 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.80 |
| Current Ratio | 2.90 |
| LT Debt/ Equity | 0.01 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 7.43 |
| Price/Book | 9.83 |
| Price/Cash Flow | 457.00 |
| Per Share Data | |
| Earnings | -0.21 |
| Sales | 5.15 |
| Book Value | 3.89 |
| Cash Flow | 0.08 |
| Business Summary | |
|---|---|
| Cepheid is a molecular diagnostics company that develops, manufactures and markets integrated systems for testing in the clinical market, as well as for application in its non-clinical market. | |
| General Information | |
| 904 Caribbean Drive
Sunnyvale, CA 94089-1189 |
|
| www.cepheid.com | |
| Industry : Electronics | |
| Sector: Technology | |
| Employees: 945 | |
| CEO: John L. Bishop | |
| Short Interest | |
| Current Month (Mil) | 8.35 |
| Previous Month (Mil) | 8.31 |
| Short Interest Ratio (Days) | 18.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -4.00 |
| Return on Investments | -5.40 |
| Profitability | |
| Gross Margin | 59.30 |
| EBIT Margin | -3.80 |
| Profit Margin | -4.10 |
Portfolios with CPHD
- Portfolio NameUser Type
- Userk44b Portfolio 1
- ProColumbia Wanger Asset Manag...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor6 Health Care Stocks to Gai...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
Latest CPHD Headlines from TheStreet
- Cepheid Stock Upgraded (CPHD) 01.25.13 | 04:01 am
- Analysts' Actions: AAPL, BHI, REG, TXN 12.17.12 | 08:12 am
- Cepheid Stock Downgraded (CPHD) 11.12.12 | 04:11 am
- Nanosphere: A Low-Risk, High-Growth Diagnostic Stock 09.18.12 | 07:09 am
- Analysts' Actions: P CI HUM LPX RDC 08.30.12 | 08:08 am
- Cepheid Management Discusses Q2 2012 Results - Earnings Call Transcript 07.19.12 | 11:07 pm
- Cepheid Stock Hits New 52-Week High (CPHD) 06.27.12 | 03:06 pm
- Cepheid Stock Falls On Unusually High Volume (CPHD) 04.20.12 | 02:04 pm
- Cepheid Stock Hits New 52-Week High (CPHD) 01.31.12 | 12:01 pm
- Cepheid Rises On Unusually High Volume (CPHD) 01.27.12 | 10:01 am
Press Releases for CPHD
- Diagnostic Marketing Association Names Cepheid 2011 Marketer Of The Year - PR Newswire 05.01.12 | 01:05 pm
- LABSCO To Distribute Cepheid GeneXpert® Systems And Tests - PR Newswire 05.19.11 | 03:05 pm
Partner Headlines for CPHD
- UPDATE: Canaccord Genuity Reiterates Cepheid at Buy with $50 PT Post Analyst Day - Benzinga 09.28.12 | 01:09 pm
- Cepheid's Preliminary 3Q Disappoints - Analyst Blog - Zacks 09.27.12 | 09:09 am
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Ultimate Market Recap: Chipotle Goes South, AT&T to Spend Billions in Buybacks - Wall St. Cheat Sheet 07.20.12 | 10:07 am
- Xyratex LOWERED Due to Weaker Q3 Guidance and 4 Active Stock Alerts to Take Note of Now - Wall St. Cheat Sheet 07.06.12 | 02:07 am
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Benzinga's Top Downgrades With Color for May 14, 2012 - Benzinga 05.14.12 | 12:05 pm
- Cepheid Incurs Loss as Costs Rise - Analyst Blog - Zacks 04.20.12 | 10:04 am
- Zacks Releases Four Powerful ''Buy'' Stocks: Cepheid, Eaton Vance, ULTA Beauty and Agrium - Press Releases - Zacks 04.12.12 | 09:04 am
- Cepheid - Aggressive Growth - Zacks 04.12.12 | 01:04 am
